Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

Wright Medical, Wrong Market

This isn't a particularly healthy environment for smaller med-techs, and Wright Medical Group (NASDAQ:WMGI) is paying the price for that sector weakness. There wasn't anything particularly wrong with Wright Medical's second quarter report, and the company continues to perform exceptionally well in the fast-growing extremities market, but there was nothing new to push analysts or investors to a more positive outlook. With market share growth potential in lower extremities, an upcoming FDA decision on Augment, and the balance sheet flexibility to do deals, there are still good reasons to hold Wright Medical, but the discount to fair value doesn't scream "must buy" right now.

Getting The Job Done, Though Only Just

Wright Medical was basically on target, but...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details